天士力：2025年归母净利润11亿元，同比增长15.68%

Core Viewpoint - Tianjin Tasly Pharmaceutical Group Co., Ltd. reported a net profit attributable to shareholders of 1.1 billion yuan for the year 2025, reflecting a year-on-year growth of 15.68% [2] Summary by Category - Company Performance - The company achieved a net profit of 1.1 billion yuan in 2025, which represents a 15.68% increase compared to the previous year [2] - Investor Communication - The company addressed investor inquiries on its interactive platform regarding its performance and future outlook [2]